{"count": 5, "results": [{"_id": "37491245", "pmid": 37491245, "pmcid": "PMC10367384", "title": "Gallic acid and metformin co-administration reduce oxidative stress, apoptosis and inflammation via Fas/caspase-3 and NF-kappaB signaling pathways in thioacetamide-induced acute hepatic encephalopathy in rats", "journal": "BMC Complement Med Ther", "authors": ["Mohamed EK", "Hafez DM"], "date": "2023-07-25T00:00:00Z", "doi": "10.1186/s12906-023-04067-9", "meta_date_publication": "2023 Jul 25", "meta_volume": "23", "meta_issue": "1", "meta_pages": "265", "score": 50272.266, "text_hl": "This study evaluates the combined effect of @CHEMICAL_Gallic_Acid @CHEMICAL_MESH:D005707 @@@gallic acid@@@ (@CHEMICAL_Gallic_Acid @CHEMICAL_MESH:D005707 @@@GA@@@), and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (@GENE_MET @GENE_24553 @@@Met@@@) on the @DISEASE_Chemical_and_Drug_Induced_Liver_Injury @DISEASE_MESH:D056486 @@@liver and brain damage@@@ associated with @<m>DISEASE_Hepatic_Encephalopathy</m> @DISEASE_MESH:D006501 @@@HE@@@.", "citations": {"NLM": "Mohamed EK, Hafez DM. Gallic acid and metformin co-administration reduce oxidative stress, apoptosis and inflammation via Fas/caspase-3 and NF-kappaB signaling pathways in thioacetamide-induced acute hepatic encephalopathy in rats BMC Complement Med Ther. 2023 Jul 25;23(1):265. PMID: 37491245", "BibTeX": "@article{37491245, title={Gallic acid and metformin co-administration reduce oxidative stress, apoptosis and inflammation via Fas/caspase-3 and NF-kappaB signaling pathways in thioacetamide-induced acute hepatic encephalopathy in rats}, author={Mohamed EK and Hafez DM}, journal={BMC Complement Med Ther}, volume={23}, number={1}, pages={265}}"}}, {"_id": "23166628", "pmid": 23166628, "pmcid": "PMC3499552", "title": "Metformin Inhibits Glutaminase Activity and Protects against Hepatic Encephalopathy", "journal": "PLoS One", "authors": ["Ampuero J", "Ranchal I", "Nuñez D", "Díaz-Herrero Mdel M", "Maraver M", "del Campo JA", "Rojas Á", "Camacho I", "Figueruela B", "Bautista JD", "Romero-Gómez M"], "date": "2012-01-01T00:00:00Z", "doi": "10.1371/journal.pone.0049279", "meta_date_publication": "2012", "meta_volume": "7", "meta_issue": "11", "meta_pages": "e49279", "score": 50074.09, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Inhibits @GENE_GLS @GENE_2744 @@@Glutaminase@@@ Activity and Protects against @<m>DISEASE_Hepatic_Encephalopathy</m> @DISEASE_MESH:D006501 @@@Hepatic Encephalopathy@@@", "citations": {"NLM": "Ampuero J, Ranchal I, Nuñez D, Díaz-Herrero Mdel M, Maraver M, del Campo JA, Rojas Á, Camacho I, Figueruela B, Bautista JD, Romero-Gómez M. Metformin Inhibits Glutaminase Activity and Protects against Hepatic Encephalopathy PLoS One. 2012;7(11):e49279. PMID: 23166628", "BibTeX": "@article{23166628, title={Metformin Inhibits Glutaminase Activity and Protects against Hepatic Encephalopathy}, author={Ampuero J and Ranchal I and Nuñez D and Díaz-Herrero Mdel M and Maraver M and del Campo JA and Rojas Á and Camacho I and Figueruela B and Bautista JD and Romero-Gómez M}, journal={PLoS One}, volume={7}, number={11}, pages={e49279}}"}}, {"_id": "29542325", "pmid": 29542325, "title": "Metformin modifies glutamine metabolism in an in vitro and in vivo model of hepatic encephalopathy.", "journal": "Rev Esp Enferm Dig", "authors": ["Gil-GÓmez A", "Gómez-Sotelo AI", "Ranchal I", "Rojas Á", "García-Valdecasas M", "Muñoz-Hernández R", "Gallego-Durán R", "Ampuero J", "Romero Gómez M"], "date": "2018-07-01T00:00:00Z", "doi": "10.17235/reed.2018.5004/2017", "meta_date_publication": "2018 Jul", "meta_volume": "110", "meta_issue": "7", "meta_pages": "427-433", "score": 50069.61, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ modifies @CHEMICAL_Glutamine @CHEMICAL_MESH:D005973 @@@glutamine@@@ metabolism in an in vitro and in vivo model of @<m>DISEASE_Hepatic_Encephalopathy</m> @DISEASE_MESH:D006501 @@@hepatic encephalopathy@@@.", "citations": {"NLM": "Gil-GÓmez A, Gómez-Sotelo AI, Ranchal I, Rojas Á, García-Valdecasas M, Muñoz-Hernández R, Gallego-Durán R, Ampuero J, Romero Gómez M. Metformin modifies glutamine metabolism in an in vitro and in vivo model of hepatic encephalopathy. Rev Esp Enferm Dig. 2018 Jul;110(7):427-433. PMID: 29542325", "BibTeX": "@article{29542325, title={Metformin modifies glutamine metabolism in an in vitro and in vivo model of hepatic encephalopathy.}, author={Gil-GÓmez A and Gómez-Sotelo AI and Ranchal I and Rojas Á and García-Valdecasas M and Muñoz-Hernández R and Gallego-Durán R and Ampuero J and Romero Gómez M}, journal={Rev Esp Enferm Dig}, volume={110}, number={7}, pages={427-433}}"}}, {"_id": "30646605", "pmid": 30646605, "pmcid": "PMC6356289", "title": "Metformin Impairs Glutamine Metabolism and Autophagy in Tumour Cells", "journal": "Cells", "authors": ["Saladini S", "Aventaggiato M", "Barreca F", "Morgante E", "Sansone L", "Russo MA", "Tafani M"], "date": "2019-01-14T00:00:00Z", "doi": "10.3390/cells8010049", "meta_date_publication": "2019 Jan 14", "meta_volume": "8", "meta_issue": "1", "meta_pages": "", "score": 50052.43, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ has been shown to inhibit @GENE_GLS @GENE_2744 @@@glutaminase@@@ (@GENE_GLS @GENE_2744 @@@GLS@@@) activity and @CHEMICAL_Ammonia @CHEMICAL_MESH:D000641 @@@ammonia@@@ accumulation thereby reducing the risk of @<m>DISEASE_Hepatic_Encephalopathy</m> @DISEASE_MESH:D006501 @@@hepatic encephalopathy@@@ in @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetic@@@ @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Saladini S, Aventaggiato M, Barreca F, Morgante E, Sansone L, Russo MA, Tafani M. Metformin Impairs Glutamine Metabolism and Autophagy in Tumour Cells Cells. 2019 Jan 14;8(1):. PMID: 30646605", "BibTeX": "@article{30646605, title={Metformin Impairs Glutamine Metabolism and Autophagy in Tumour Cells}, author={Saladini S and Aventaggiato M and Barreca F and Morgante E and Sansone L and Russo MA and Tafani M}, journal={Cells}, volume={8}, number={1}}"}}, {"_id": "18929879", "pmid": 18929879, "title": "Successful management of a type 2 diabetic donor in living-donor liver transplantation: a case report.", "journal": "Transplant Proc", "authors": ["Kobayashi T", "Sato Y", "Yamamoto S", "Oya H", "Kokai H", "Kurosaki I", "Hatakeyama K"], "date": "2008-10-01T00:00:00Z", "doi": "10.1016/j.transproceed.2008.07.021", "meta_date_publication": "2008 Oct", "meta_volume": "40", "meta_issue": "8", "meta_pages": "2842-3", "score": 50042.42, "text_hl": "She stopped using @GENE_INS @GENE_3630 @@@insulin@@@ and returned to @CHEMICAL_Nateglinide @CHEMICAL_MESH:D000077715 @@@nateglinide@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin hydrochloride@@@ on postoperative day 25. ", "citations": {"NLM": "Kobayashi T, Sato Y, Yamamoto S, Oya H, Kokai H, Kurosaki I, Hatakeyama K. Successful management of a type 2 diabetic donor in living-donor liver transplantation: a case report. Transplant Proc. 2008 Oct;40(8):2842-3. PMID: 18929879", "BibTeX": "@article{18929879, title={Successful management of a type 2 diabetic donor in living-donor liver transplantation: a case report.}, author={Kobayashi T and Sato Y and Yamamoto S and Oya H and Kokai H and Kurosaki I and Hatakeyama K}, journal={Transplant Proc}, volume={40}, number={8}, pages={2842-3}}"}}]}